News
Market Data
Register for real-time alerts, custom portfolio, and market movers
The current APGE market cap is 2.68B. The company's latest EPS is USD -1.6580 and P/E is -31.98.
| Quarter End | |
|---|---|
| USD ($) | |
| Total Revenue | |
| Operating Income | |
| Net Income |
| Year End December 30 2023 | 2023 |
|---|---|
| USD ($) | |
| Total Revenue | 0 |
| Operating Income | -93M |
| Net Income | -83.99M |
| Quarter End | |
|---|---|
| USD ($) | |
| Total Assets | |
| Total Liabilities | |
| Total Equity |
| Year End December 30 2023 | 2023 |
|---|---|
| USD ($) | |
| Total Assets | 401.4M |
| Total Liabilities | 21.49M |
| Total Equity | 379.91M |
| Market Cap | 2.68B |
| Price to Earnings Ratio | -31.98 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 22.7 |
| Price to Book Ratio | 7.07 |
| Dividend Yield | - |
| Shares Outstanding | 50.66M |
| Average Volume (1 week) | 259.99k |
| Average Volume (1 Month) | 331.18k |
| 52 Week Change | 146.14% |
| 52 Week High | 72.29 |
| 52 Week Low | 14.19 |
| Spread (Intraday) | 7.43 (12.41%) |
| Company Name | Apogee Therapeutics Inc |
| Address |
1209 orange st wilmington, delaware 19801 |
| Website | https://www.apogeetherapeutics.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
